Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IDEA-068
- Development stage
- Phase 2
- Lead developer
- IDEA
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
IDEA-068 is a topical formulation of methotrexate (MTX) utilizing the proprietary Transfersome technology developed by Idea AG. Transfersomes are highly deformable, complex lipid vesicles designed to penetrate the skin barrier more effectively than conventional liposomes by squeezing through narrow intercellular spaces in the stratum corneum. In the treatment of chronic stable plaque psoriasis, IDEA-068 is intended to deliver MTX directly to the epidermis and dermis to inhibit dihydrofolate reductase (DHFR), thereby reducing keratinocyte proliferation and local inflammation while minimizing the systemic side effects associated with oral MTX administration. The drug reached Phase 2 clinical development, including a randomized, double-blind, dose-finding study in Germany that compared multiple doses of IDEA-068 to clobetasol propionate (Dermoxinale) and placebo.
- Other names
- methotrexate Transfersomes
02
Targets
DHFR (Dihydrofolate reductase)
Beyond the preview
Go deeper on IDEA-068.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IDEA-068.